Responses
Review
Botulinum toxin in clinical practice
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 12 July 2004
- Published on: 12 July 2004Botulinum toxin for treatment of migraine: randomized controlled trials versus basic sciencesShow More
Dear Editor
Jankovic reviews the expanding list of approved and off-label indications for therapeutic use of botulinum toxin (BT). [1]. One of the prominent off-label indications for use of BT is migraine, the advent of which therapy was serendipitous.
Use of BT for migraine prevention is gaining momentum through the results of randomized controlled trials (RCT) – both completed and ongoing – and, in th...
Conflict of Interest:
None declared.